Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
This report contains market size and forecasts of Human Blood Plasma Fractionation in Global, including the following market information:
Global Human Blood Plasma Fractionation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Blood Plasma Fractionation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune Globulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Blood Plasma Fractionation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Blood Plasma Fractionation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Blood Plasma Fractionation Market Segment Percentages, by Type, 2021 (%)
Immune Globulin
Coagulation Factor
Albumin
Other
Global Human Blood Plasma Fractionation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Blood Plasma Fractionation Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Human Blood Plasma Fractionation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Blood Plasma Fractionation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Blood Plasma Fractionation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Blood Plasma Fractionation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics